Skip to content
Clinical Trials – home

Clinirem Sp. z o.o.

Verified siteinfo

Poland Ul. Polnocna 24/U1, 20-064 Lublin, Poland

  • 10 trials recruiting
  • Chronic inflammatory demyelinating polyradiculoneuropathy · Myasthenia gravis · Dementia Alzheimer's type
  • Adult patients

About Specializations

Clinirem Sp. z o.o. in Lublin, Poland specialises in clinical trials of conditions such as Chronic inflammatory demyelinating polyradiculoneuropathy, Myasthenia gravis, Dementia Alzheimer's type, Migraine, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology and Headache Research

At Clinirem Sp. z o.o. in Lublin, clinical research in nervous system diseases focuses on episodic migraine. The studies are designed to evaluate whether a new treatment can help reduce migraine burden and improve symptom control for people living with frequent attacks.

  • Focus on episodic migraine within neurological research
  • Assessment of a therapy intended to lower monthly migraine days
  • Interest in both treatment effectiveness and patient well-being

This research supports better options for preventing migraines and improving everyday functioning for patients affected by recurrent headache disorders.

Autoimmune and Neuromuscular Disease Studies

The site is also conducting work in immune system diseases, with a strong emphasis on generalized myasthenia gravis. These trials aim to understand whether a new therapy can be safe and effective for people with this chronic autoimmune condition that affects muscle strength.

  • Research in generalized myasthenia gravis under immunology
  • Evaluation of a treatment targeting disease activity and symptom relief
  • Clinical interest in safety, tolerability, and therapeutic benefit

Through this work, Clinirem Sp. z o.o. contributes to advancing treatment choices for patients living with complex immune-related disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Polnocna 24/U120-064 LublinPoland
Recruiting now
10 trials
Conditions studied
8
Partner status
Verified site

More sites in LublinPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

23 clinical trials

Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Pharmacokinetics and safety of subcutaneous vs intravenous human normal immunoglobulin in adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:Grifols Therapeutics LLC

AUR200 for Patients with Generalized Myasthenia Gravis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AUR200

A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Study of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.

Comparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:Takeda Development Center Americas Inc.

Study on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:NMD670
  • Sponsor:NMD Pharma A/S

Study on Nipocalimab for Adults with Generalized Myasthenia Gravis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Study on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Migraine

Not recruiting

Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Lu Ag09222
  • Sponsor:H. Lundbeck A/S

Myasthenia gravis

Not recruiting

Study on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zilucoplan
  • Sponsor:UCB Biopharma
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.